An introduction to the topic of Freedom of Association.

Organisations and reference material relating to Freedom of Association.

This briefing document seeks to explain clearly what freedom of association and the right to collective bargaining mean.

Links to organisations involved in the fair treatment of employees, along with reference material.

An introduction to the issue of harassment in the workplace.

Links to additional resources including organisations involved in ending child labor and reference material.

An example of how to deal with child labor.

An introduction to child labor & young workers.

Information on tackling child labour in Global Supply Chains from the Danish Ethical Trading Initiative.

Risk identification model Flubendazole

RBEAP solvent template

Risk Based Exposure Assessment Process

Guidelines and Instructions for Using Risk Based Exposure Assessment Process (RBEAP) Form

Objectives: To provide a tool and system that helps organize and document the decision for establishing an IH sampling strategy to assess risk.

Risk Based Exposure Assessment Process (RBEAP)

UNICEF Resource on Child Labor Issues

Companies should use a management system to facilitate continual improvement and compliance with labor standards.

Resources including Organisations and Reference Material.

The practical handbook on Business and Human Rights.

Bayer's sustainable development policy.

Multiple resources concerning the supply chain from UN Global Compact.

Once the hazards in the workplace have been identified and categorized by type, location and degree, appropriate preventive and protective steps should be taken to deal with the hazards. Although Worker Protection is commonly equated to Personal Protective Equipment (PPE), PPE should actually be the last line of defence in the effort to protect workers.

This document has been developed as a program guideline for companies who are
required to have a written Hearing Conservation Program.

Handling cytostatic drugs requires a number of organizational and technical systems in order to guarantee the best possible protection for personnel. This booklet focuses on various ways of protecting personnel from potential hazards through the careful handling of cytostatic drugs, and for this reason, product protection is only briefly discussed.

Process Safety Management (PSM) is recognized as Good Manufacturing Practice. In many countries PSM is covered by specific regulations. The general intent of PSM is to provide safe processes that define and manage risk based on common management practice designed to identify and mitigate hazards.

PowerPoint on dust hazards, their identification and communication.

Biological hazards arise from exposure to hormones, viruses, fungi, bacteria or any other living organisms that can cause harm, illness, or damage to the human body.

Each chemical is different from the next one and therefore each chemical has different characteristics that help define the hazards that may be present.

Physical hazards are those hazards arising from work-related tasks as well as from the physical environment in which work is being performed.

The purpose of the non-ionizing radiation safety program is to ensure the safe use of Non-Ionizing Radiation (NIR) sources and to meet the expectations of the Standards.

Pharmaceutical Industry’s Approach to Safe Handling of New Molecular Entities.

Example of a document produced after a fatality.

Equipment containment performance: Potent and highly potent active pharmaceutical ingredients have the potential to cause serious health effects in workers at very low airborne concentrations. The use of containment equipment as part of a systematic approach to potent compound safety is advised to control worker exposure. However the containment performance of equipment can not be assumed, evaluation of containment performance, using a standardised approach, should be adopted.

An overview of Industrial hygiene and hazard assessment in the workplace.

This paper provides an overview of some of the current best practices which have been developed for external manufacturing for both the Chemical and Pharmaceutical industries.

This chart is provided as a general guide for plastic chemical and condition compatibility.

This handbook is provided to owners, proprietors and managers of small businesses by the Occupational Safety and Health Administration (OSHA), an agency of the U.S. Department of Labor. It should help small business employers meet the legal requirements imposed by the Occupational Safety and Health Act of 1970 (the Act), and achieve an in-compliance status before an OSHA inspection.

The Premier Directory of Industrial Hygiene and Occupational and Environmental Health and Safety Consulting Professionals.

The UK Bribery Act, which was passed in 2010, introduces an offence of corporate failure to prevent bribery. The defence for a company against this liability is to prove that it had adequate procedures in place to prevent bribery. This Guidance from Transparency International UK (TI-UK) is designed to assist companies to comply with the Bribery Act by providing clear, practical advice on good practice anti-bribery systems that in TI-UK's opinion constitute 'adequate procedures' for compliance with the Bribery Act.

The link provides Bayer’s principles for animal welfare and animal testing and their responsibility for the safety of our products and thus for people, animals and the environment, and the well-being of laboratory animals.

The Novo Nordisk Way, an example of the Business Code of Conduct.

Keeping a facility clean helps improve productivity and employee morale. In addition, it
presents a positive image to customers, stakeholders and the community. A clean facility can also help ensure greater compliance with environmental, health and safety regulations. Leaks and spills can happen anywhere – from the front office to the shipping dock; and beyond. These spills create waste and can lead to costly environmental fines - especially if the spill leaves the facility. Leaks and spills can also contribute to worker injuries, causing piles of medical bills, workman’s compensation claims and lost work time.

An example is Bayer's “Science For A Better Life” where they promise innovative solutions to global economic, ecological and social challenges. The availability of fresh water is a growing concern around the world. Water is not only essential for life on earth but also for many industry sectors of the global economy and for us as a pharmaceutical and chemical company with energy and water intensive operations.

An example is Novo Nordisk's climate strategy, which is developed in accordance with the Greenhouse Gas Protocol. It includes all scope 1 and 2 emissions within operational control and scope 3 emissions that are significant in size or significant from a stakeholder perspective. Towards 2020 their focus is on reporting and reducing emissions from global production sites, company cars, product distribution and business travel.

http://www.novonordisk.com/about-novo-nordisk/novo-nordisk-in-brief/positions/climate-change.html

A wide range of tools designed by GEMI to help companies improve the environment and provide business value.

The PMI Calculator enables you to quickly determine the PMI value by accounting for the raw material inputs and bulk API outputs of a process.

Updated Version - http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/roundtable/Convergent-PMI-Tool.xlsx

The PMI Calculator enables you to quickly determine the PMI value by accounting for the raw material inputs and bulk API outputs of a process.

Updated Version - http://www.acs.org/content/dam/acsorg/greenchemistry/industriainnovation/roundtable/Convergent-PMI-Presentation.pptx

The ACS GCI Pharmaceutical Roundtable Solvent Selection Guide .

Update: Another selection guide (2015) has been published as a scientific paper. http://pubs.rsc.org/en/content/articlepdf/2016/gc/c5gc01008j

Through the application of the PSCI Principles, better social, economic and environmental outcomes will result for all those involved in the pharmaceutical supply chain. As an industry, we will focus our efforts on positive social and environmental changes, and building supply chain capacity.

Through the application of the PSCI Principles, better social, economic and environmental outcomes will result for all those involved in the pharmaceutical supply chain. As an industry, we will focus our efforts on positive social and environmental changes, and building supply chain capacity.